Fredrik Sjövall

ABOUT US Phargentis SA is a privately owned Virtual Drug Development Company located in Switzerland. Founded in 2015 and headquartered in Lugano, it is part of the privately owned group Chemholding SA. Phargentis founders have more than 40 years experience in Pharmaceutical field. ➡ WHAT WE DO We develop complex dosage forms enabling Early Market Entry Generic Drugs and innovative SuperGeneric products. We deal with licensing-out to leading Pharma partners worldwide for market access and fit for purpose. ➡ CORE THERAPIES We work actively to create a robust portfolio of treatments to address Respiratory Diseases and we foresee future expansion in Oncology. Learn more about Phargentis on www.phargentis.ch

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

Making Every Sample Count Every year millions of blood samples worldwide cannot be analyzed because of hemolysis. Hemcheck is providing services for quality assurance of blood samples. The concept (Helge) detects hemolysis, within a few seconds, in blood samples (vacuum tubes as well as blood gas syringes) at the point of care. Saving lives, reducing costs and improving the healthcare quality. Making every sample count. About Us Hemcheck Sweden AB (hemCheck) is a privately held medical technology company based in Karlstad, Sweden. hemCheck was founded in 2010 based on an invention by Mathias Karlsson. Please visit our website, www.hemcheck.com, for more information or contact us to schedule a personal meeting. Contact Us Hemcheck Sweden AB Karlstads universitet Universitetsgatan 2 651 88 Karlstad Sweden Joen Averstad, CEO Joen.averstad@hemcheck.com

ABOUT US Phargentis SA is a privately owned Virtual Drug Development Company located in Switzerland. Founded in 2015 and headquartered in Lugano, it is part of the privately owned group Chemholding SA. Phargentis founders have more than 40 years experience in Pharmaceutical field. ➡ WHAT WE DO We develop complex dosage forms enabling Early Market Entry Generic Drugs and innovative SuperGeneric products. We deal with licensing-out to leading Pharma partners worldwide for market access and fit for purpose. ➡ CORE THERAPIES We work actively to create a robust portfolio of treatments to address Respiratory Diseases and we foresee future expansion in Oncology. Learn more about Phargentis on www.phargentis.ch

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

Almi Invest is Sweden’s most active startup investor. We invest all over Sweden through seven regional VC-funds and one national Green Tech fund. Almi Invest manages a total equity of SEK 3,5 billion and has since start invested in almost 1 000 startups. Our best holdings have been divested to major industry players such as Google, Apple, Microsoft and Qlik or through IPOs. Almi Invest is a venture capital company within the Almi Group and financed by European Regional Development Fund, Almi, Almi Invest and regional representatives.

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

Making Every Sample Count Every year millions of blood samples worldwide cannot be analyzed because of hemolysis. Hemcheck is providing services for quality assurance of blood samples. The concept (Helge) detects hemolysis, within a few seconds, in blood samples (vacuum tubes as well as blood gas syringes) at the point of care. Saving lives, reducing costs and improving the healthcare quality. Making every sample count. About Us Hemcheck Sweden AB (hemCheck) is a privately held medical technology company based in Karlstad, Sweden. hemCheck was founded in 2010 based on an invention by Mathias Karlsson. Please visit our website, www.hemcheck.com, for more information or contact us to schedule a personal meeting. Contact Us Hemcheck Sweden AB Karlstads universitet Universitetsgatan 2 651 88 Karlstad Sweden Joen Averstad, CEO Joen.averstad@hemcheck.com